PRVA Stock: Price, Earnings History and SEC Filings
Privia Health Group, Inc. (PRVA) last traded at $21.48, down 2.34% on the latest session and up 9.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.07 against an analyst estimate of $0.08, a miss of 12.5%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PRVA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.07 | $0.08 | -12.50% |
| Mar 2026 | May 7, 2026 | $0.02 | $0.08 | -75.00% |
| Dec 2025 | Feb 26, 2026 | $0.07 | $0.04 | +75.00% |
| Sep 2025 | Nov 6, 2025 | $0.05 | $0.06 | -16.67% |
PRVA beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
How PRVA reacts to earnings
Across its last 8 earnings releases, PRVA moved 5.4% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | Before open | -8.18% |
| 2026-05-07 | Before open | +0.00% |
| 2026-02-26 | Before open | +9.98% |
| 2025-11-06 | Before open | -4.16% |
| 2025-08-07 | Before open | -1.37% |
| 2025-05-08 | Before open | +7.50% |
| 2025-02-27 | Before open | +5.82% |
| 2024-11-07 | Before open | +6.47% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
PRVA financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2.1B | $23M | – | 1.1% | $0.18 |
| 2024 | $1.7B | $14M | – | 0.8% | $0.11 |
| 2023 | $1.7B | $23M | $81M | 1.4% | $0.19 |
| 2022 | $1.4B | -$9M | $47M | -0.6% | $-0.08 |
| 2021 | $966M | -$188M | $55M | -19.5% | $-1.83 |
| 2020 | $817M | $31M | $39M | 3.8% | $0.33 |
| 2019 | $786M | $8M | $19M | 1.0% | $0.09 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for PRVA
- 8-K · Aug 18, 2026Officer or director change, Financial statements and exhibits
- 10-Q · Aug 6, 2026
- 8-K · Aug 6, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 7, 2026Officer or director change
- 8-K · May 22, 2026Shareholder vote
- 10-Q · May 7, 2026
- 8-K · May 7, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 2, 2026
- 10-K · Feb 27, 2026
- 8-K · Feb 26, 2026Results of operations, Financial statements and exhibits
Insider filing activity
PRVA insiders filed 1 Form 4 report in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
PRVA news
- 2 healthcare stocks with solid fundamentals and 1 we questionOct 27, 2026 · finance.yahoo.com
- 2 Profitable Stocks for Long-Term Investors and 1 We IgnoreOct 19, 2026 · finance.yahoo.com
About Privia Health Group, Inc.
Privia Health Group, Inc. (PRVA) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-health Services. It is incorporated in DE. Its fiscal year ends in December.